Nine ovarian and one cervical cancer cell lines were evaluated by co-immunofluorescence (co-IF), proximity ligation assay (PLA), co-immunoprecipitation (co-IP), and the p53-Seprion-ELISA. This evidence concerns the gene TP53 and cervical cancer.